Participants enrolled for CME credit will be asked to read each question, select an answer, and review the corresponding critique and preferred answer. Participants will test their mastery of the content just learned by answering the same questions in a scrambled fashion and must achieve a cumulative score of 80 percent. If the score is less than 80 percent, the learner will be asked to review only the questions answered incorrectly and answer those questions again until a cumulative score of 80 percent is achieved. If a score of 80 percent correct is not achieved after the third round, the learner will be asked to start the entire section over again.
If a category has multiple parts, each part must be completed with a score of 80 percent to claim credit for the entire category. After achieving a score of 80 percent for each category, participants will be asked to complete an evaluation form and submit data to the American College of Surgeons (ACS) using the Internet. Upon successful submission, a CME certificate will be available to print. SESAP 17 is certified for credit through October 2022.
Disclosure Information
In accordance with the ACCME Accreditation Criteria, the ACS must ensure that anyone in a position to control the content of the educational activity (planners and authors) has disclosed all financial relationships with any commercial interest, as defined as follows:
Commercial Interest: The ACCME defines a commercial interest as any entity producing, marketing, reselling, or distributing healthcare goods or services used on or consumed by patients. Providers of clinical services directly to patients are NOT included in this definition.
Financial Relationships: Relationships in which the individual benefits by receiving a salary, royalty, intellectual property rights, consulting fee, honoraria, ownership interest (e.g., stocks, stock options, or other ownership interest, excluding diversified mutual funds), or other financial benefit. Financial benefits are usually associated with roles such as employment, management position, independent contractor (including contracted research), consulting, speaking and teaching, membership on advisory committees or review panels, board membership, and other activities from which remuneration is received, or expected. ACCME considers relationships of the person involved in the CME activity to include financial relationships of a spouse or partner.
Conflict of Interest: Circumstances create a conflict of interest when an individual has an opportunity to affect CME content about products or services of a commercial interest with which he/she has a financial relationship.
The ACCME also requires that the ACS manage any reported conflict and eliminate the potential for bias during the educational activity. Any conflicts noted below have been managed to our satisfaction. The disclosure information is intended to identify any commercial relationships and allow learners to form their own judgments. However, if you perceive a bias during the educational activity, please report it on the evaluation.
Planning Committee
John A. Weigelt, MD, DVM, FACS, Chair (Nothing to disclose)
Richard M. Bell, MD, FACS (Nothing to disclose)
David C. Borgstrom, MD, MBA, FACS (Nothing to disclose)
David A. Bull, MD, FACS (Nothing to disclose)
Jeffrey G. Chipman, MD, FACS (Nothing to disclose)
Mary E. Fallat, MD, FACS (Nothing to disclose)
Jason B. Fleming, MD, FACS (Nothing to disclose)
Charles M. Friel, MD, FACS, FASCRS (Nothing to disclose)
Richard P. M. Koehler, MD, FACS (Nothing to disclose)
Lorrie A. Langdale, MD, FACS (Nothing to disclose)
Lena M. Napolitano, MD, FACS, FCCP, MCCM (Nothing to disclose)
John T. Paige, MD, FACS (Co-editor—Oxford University Press; Faculty—Health Resources and Services Administration; Co-Principal Investigator— Louisiana State University Board of Regents; Principal Investigator— Acell, Inc., Southern Group on Educational Affairs)
David A. Spain, MD, FACS (Nothing to disclose)
James G. Tyburski, MD, FACS (Nothing to disclose)
R. James Valentine, MD, FACS (Nothing to disclose)
Daniel Vargo, MD, FACS (Nothing to disclose)
John T. Vetto, MD, FACS (Spouse’s employer—Genentech, Inc.; Honorarium—Castle Biotech)
Travis P. Webb, MD, MHPE, FACS (Nothing to disclose)
Catherine M. Wittgen, MD, FACS (Consultant—Grafix, Organogenesis, Bristol Myers Squibb, CVRx, Inc.; Adjudicator—Bayer HealthCare Pharmaceuticals, Inc.; Speaker—Tactile Medical)
Authors
John A. Weigelt, MD, DVM, FACS, Chair (Nothing to disclose)
Richard M. Bell, MD, FACS (Nothing to disclose)
Frederic S. Bongard, MD, JD, FACS (Nothing to disclose)
David C. Borgstrom, MD, MBA, FACS (Nothing to disclose)
Tawnya L. Bowles, MD, FACS (Nothing to disclose)
David A. Bull, MD, FACS (Nothing to disclose)
Clay Cothren Burlew, MD, FACS (Nothing to disclose)
Casey M. Calkins, MD, FACS (Nothing to disclose)
Jeremy W. Cannon, MD, SM, FACS (Author –Up to Date, Inc.; Reviewer—US Department of Defense CDMRP)
Jeffrey G. Chipman, MD, FACS (Nothing to disclose)
Quyen D. Chu, MD, FACS (Nothing to disclose)
Jay J. Doucet, MD, MSc, FRCSC, FACS, RDMS (Nothing to disclose)
Dan Eisenberg, MD, MS, FACS, FASMBS (Nothing to disclose)
Mary E. Fallat, MD, FACS (Nothing to disclose)
Jason B. Fleming, MD, FACS (Nothing to disclose)
Charles M. Friel, MD, FACS, FASCRS (Nothing to disclose)
David A. Gerber, MD, FACS (Nothing to disclose)
Nicole S. Gibran, MD, FACS (Nothing to disclose)
Uzer Khan, MD, MBBS, FACS (Nothing to disclose)
Tari A. King, MD, FACS (Speaker—Genomic Health and Oncoclinicas)
Richard P. M. Koehler, MD, FACS (Nothing to disclose)
Mary R. Kwaan, MD, MPH, FACS (Nothing to disclose)
Lorrie A. Langdale, MD, FACS (Nothing to disclose)
Sean J. Langenfeld, MD, FACS, FASCRS (Nothing to disclose)
COL Robert B. Lim, MD, FACS (Consultant–Up to Date, Inc.)
Fred A. Luchette, MD, MSc, FACS (Nothing to disclose)
Linda L. Maerz, MD, FACS, FCCM (Nothing to disclose)
Linda W. Martin, MD, MPH, FACS (Speaker—American Society of Clinical Oncology)
David J. Milia, MD, FACS (Nothing to disclose)
Forrest O. Moore, MD, FACS (Editor—Wiley-Blackwell)
Nicholas Namias, MD, MBA, FACS, FCCM (Nothing to disclose)
Lena M. Napolitano, MD, FACS, FCCP, MCCM (Nothing to disclose)
Leigh A. Neumayer, MD, MS, FACS (Stockholder—Alphabet, Inc.; Celgene Corporation; Baidu, Inc.; Gilead Sciences, Inc.; Intrexon Corporation; Edwards Lifesciences; Regeneron Pharmaceuticals)
John T. Paige, MD, FACS (Co-editor—Oxford University Press; Faculty—Health Resources and Services Administration; Co-Principal Investigator— Louisiana State University Board of Regents; Principal Investigator— Acell, Inc., Southern Group on Educational Affairs)
Sharla Gayle Patterson, MD, MBA(HOM), FACS (Speaker’s bureau—Invuity, Inc.; Myriad Genetics, Inc.; Focal Therapeutics, Inc.; Medtronic; Committee member and course co-chair—American Society of Breast Surgeons)
Jasmeet S. Paul, MD, FACS (Nothing to disclose)
Daryl P. Pearlstein, MD, FACS (Consultant—Intuitive Surgical, Inc.)
Tam N. Pham, MD, FACS (Nothing to disclose)
Walter E. Pofahl II, MD, FACS (Nothing to disclose)
Trent D. Proehl, MD, FACS (Nothing to disclose)
Paul J. Schenarts, MD, FACS (Nothing to disclose)
David G. Sheldon, MD, FACS (Nothing to disclose)
Shayna L. Showalter, MD, FACS (Nothing to disclose)
Timothy R. Siegel, MD, FACS (Nothing to disclose)
David A. Spain, MD, FACS (Nothing to disclose)
Lance E. Stuke, MD, MPH, FACS (Nothing to disclose)
Kiran K. Turaga, MBBS, FACS (Consultant—Caris Life Sciences, Castle)
James G. Tyburski, MD, FACS (Nothing to disclose)
R. James Valentine, MD, FACS (Nothing to disclose)
Daniel Vargo, MD, FACS (Nothing to disclose)
John T. Vetto, MD, FACS (Spouse’s employer—Genentech, Inc.; Honorarium—Castle Biotech)
Tracy S. Wang, MD, MPH, FACS (Nothing to disclose)
Travis P. Webb, MD, MHPE, FACS (Nothing to disclose)
Catherine M. Wittgen, MD, FACS (Consultant—Grafix, Organogenesis, Bristol Myers Squibb, CVRx, Inc.; Adjudicator—Bayer HealthCare Pharmaceuticals, Inc.; Speaker—Tactile Medical)
Consultants
Ajit K. Sachdeva, MD, FACS, FRCSC, FSACME (Nothing to disclose)
Patrice Gabler Blair, MPH (Nothing to disclose)
Staff
Julia C. Dudek, MPH (Nothing to disclose)
Chrysa M. Cullather, MS (Nothing to disclose)
Katherine M. Greenock, MS (Nothing to disclose)
Education Credits of Excellence
Education Credits of Excellence are entirely optional and are designed to encourage further learning and to challenge surgeons who want to pursue a higher level of recognition. For each SESAP category, surgeons who achieve a score of 100% on the first attempt of the CME Test will be recognized with Education Credits of Excellence for that category. Surgeons are able and encouraged to study the items in the self-assessment portion as much as they wish prior to taking the CME test. Those surgeons who achieve 100 percent on the first attempt of the CME test for a category (or each part for categories with multiple parts) will receive a certificate for Education Credits of Excellence for that category. Education Credits of Excellence are being offered by the ACS Division of Education, as supported by the ACS Board of Regents. Certificates for Education Credits of Excellence may be accessed in the SESAP 17 web program.
Royal College of Physicians and Surgeons of Canada Accreditation
Through an agreement between the American College of Surgeons and the Royal College of Physicians and Surgeons of Canada, MOC Program participants may record completed self-assessment programs or simulation activities developed and accredited by the American College of Surgeons in Section 3 of the Royal College's MOC Program. Please note that in order to qualify for the Royal College Section 3 MOC, learners must participate in CME-eligible SESAP packages.